PeriRx Kicks Off 2015 with Debut at Yankee Dental Congress

Company Will Feature its SaliMark OSCC Salivary Test for Oral Cancer
Posted: January 23, 2015
Edited by Dentaltown staff

BROOMALL, Penn.—PeriRx, a developer of non-invasive oral diagnostic technology, will kick off 2015 with its first-time participation at the Yankee Dental Congress in Boston.

The company will be exhibiting from January 29th to January 31st.  

“We’re very excited to start the year strong at the Yankee Dental Congress,” said Stephen M. Swanick, CEO and founder of PeriRx. “The new year represents a fresh start and a time to consider making progressive and positive changes. We strongly believe this applies to raising the bar on how we detect oral cancer, the sixth most prevalent form of cancer in the United States with more than 43,000 newly-diagnosed cases per year.” 

The mortality rate for oral cancer is alarmingly high, with more than 8,000 deaths every year which equates to one person dying every hour, 24 hours per day.

“Earlier detection via molecular DNA testing can reverse these statistics,” added Swanick.

PeriRx will employ several ways to inform Yankee Dental Congress attendees about SaliMark OSCC, a molecular DNA biomarker test for oral squamous cell carcinoma, which is scheduled to ship via several national dental distributors before the end of the first quarter. 

In addition to exhibiting at the convention, PeriRx will be introducing SaliMark OSCC with a free CE Course and free SaliMark OSCC Test Kit. 

 
Sponsors
Townie Perks
Townie® Poll
Have you ever switched practice management platforms for your practice?
  
Sally Gross, Member Services Specialist
Phone: +1-480-445-9710
Email: sally@farranmedia.com
©2024 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450